STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNMD
  4. [Form 4] CONMED Corp Insider Trading Activity

CONMED (NYSE: CNMD) director awarded 5,772 RSUs and converts 668 into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CONMED Corp director Barbara J. Schwarzentraub reported equity compensation and a routine option-like exercise. She received 5,772 RSUs on June 1, 2026, each representing a contingent right to one share of common stock under the 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after one year. On June 2, 2026, 668 RSUs were exercised and converted into 668 shares of common stock, leaving her with 5,012 shares of common stock held directly. A separate line shows 1,442 shares of common stock held indirectly by The Barbara J. Schwarzentraub Trust.

Positive

  • None.

Negative

  • None.
Insider Schwarzentraub Barbara J
Role null
Type Security Shares Price Value
Exercise RSUs (Restricted Stock Units) 668 $0.00 --
Exercise Common Stock 668 $0.00 --
Grant/Award RSUs (Restricted Stock Units) 5,772 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: RSUs (Restricted Stock Units) — 0 shares (Direct, null); Common Stock — 5,012 shares (Direct, null); Common Stock — 1,442 shares (Indirect, by The Barbara J. Schwarzentraub Trust)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
RSUs granted 5,772 RSUs Grant on June 1, 2026 under 2025 Long-Term Incentive Plan
RSU exercise 668 RSUs Exercised and converted into common stock on June 2, 2026
Direct common stock holding 5,012 shares Shares of CONMED common stock held directly after June 2, 2026 transaction
Indirect common stock holding 1,442 shares Common stock held indirectly by The Barbara J. Schwarzentraub Trust
RSU vesting schedule 100% after one year Vesting terms for RSUs under 2025 Long-Term Incentive Plan
RSU conversion price $0.00 per unit Stated conversion/exercise price for RSUs in the filing
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Long-Term Incentive Plan financial
"will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"
contingent right to receive one share of common stock financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
indirect ownership financial
"Common Stock ... indirect ... by The Barbara J. Schwarzentraub Trust"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schwarzentraub Barbara J
(Last)(First)(Middle)
C/O CONMED CORPORATION
11311 CONCEPT BOULEVARD
(Street)
LARGO FLORIDA 33773
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026M668A$05,012D
Common Stock1,442Iby The Barbara J. Schwarzentraub Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
RSUs (Restricted Stock Units)$006/01/2026A5,77206/01/2027(1)06/01/2036Common Stock5,772$05,772D
RSUs (Restricted Stock Units)$006/02/2026M66806/02/2026(2)06/02/2035Common Stock668$00D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
/s/ Thomas Fistek for Barbara J. Schwarzentraub by Power of Attorney06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did CONMED (CNMD) director Barbara J. Schwarzentraub report?

Barbara J. Schwarzentraub reported a grant of 5,772 RSUs and the exercise of 668 RSUs into common stock. These transactions reflect equity compensation and a routine conversion of restricted stock units into 668 shares of CONMED common stock.

How many RSUs did Barbara J. Schwarzentraub receive in the latest CONMED Form 4?

She received 5,772 restricted stock units. Each RSU represents a contingent right to receive one share of CONMED common stock, generally vesting 100% after a one-year period under the company’s 2025 Long-Term Incentive Plan.

What did the 668-share transaction in CONMED (CNMD) director’s Form 4 represent?

The 668-share transaction represents the exercise of 668 RSUs into 668 shares of CONMED common stock at a stated price of $0.00 per unit. After this exercise, she directly held 5,012 shares of common stock according to the filing.

How many CONMED shares does Barbara J. Schwarzentraub hold indirectly through a trust?

The filing shows 1,442 shares of CONMED common stock held indirectly by The Barbara J. Schwarzentraub Trust. This line is classified as indirect ownership and separate from her 5,012 directly held shares following the reported transactions.

When do Barbara J. Schwarzentraub’s newly granted CONMED RSUs generally vest?

The newly granted RSUs generally vest 100% after a one-year period. They are issued under CONMED’s 2025 Long-Term Incentive Plan, with each restricted stock unit converting into one share of common stock upon vesting, subject to the plan’s terms and conditions.